Drug Shortage Report for ADDYI
Report ID | 256352 |
Drug Identification Number | 02473550 |
Brand name | ADDYI |
Common or Proper name | Addyi 100MG |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | FLIBANSERIN |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 30 tablets |
ATC code | G02CX |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2025-05-01 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-05-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2025-05-02 | French | Compare |
v1 | 2025-05-02 | English | Compare |
Showing 1 to 2 of 2